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Shoul der (or subacromial) impingement syndrome (SIS) is the most frequent disorder involving the shoulder, accounting for 44% to 65% of all shoulder complaints. 1 It encompasses a spectrum of subacromial space pathologies, including rotator cuff tear/tendinosis, calcific tendinitis, and subacromial bursitis. Its main consequences are pain, loss of function, and disability. 2 Commonly, nonoperative options are preferred at the initial step, that is, nonsteroidal anti-inflammatory drugs (NSAIDs) and exercise therapy. 3 Other nonoperative alternatives would include subacromial corticosteroid (with/ without local anesthetic) injection, prolotherapy, local ice/heat therapy, electrotherapy, manual joint mobilization, extracorporeal shockwave therapy, massage, acupuncture, and kinesiotaping. 1Y8 It has been reported that oral NSAIDs appear to be more effective than placebo, and exercise therapy more effective than no treatment in reducing pain and improving shoulder function. 3 Subacromial corticosteroid injection for painful shoulder problems was found to be effective when compared with other treatment methods such as placebo, physiotherapy, and exercise within the first 8 weeks. 3, 4 ,9Y11 Corticosteroid injections in the short term are not more effective than NSAIDs in reducing pain. 3 Recently, there are also studies showing the effectiveness of kinesiotaping in the treatment of SIS. 1,7,12Y15 In those studies, kinesiotaping was compared with manipulative treatment, physiotherapy, and placebo. However, to the best knowledge of the authors, additional effects of kinesiotaping and corticosteroid injection when applied with NSAIDs have not been studied in the pertinent literature. Therefore, the aim of this study was to investigate whether kinesiotaping or subacromial corticosteroid injection provides additional benefit when used in combination with an oral NSAID treatment in patients with SIS.
METHODS
Patients with a clinical diagnosis of SIS were consecutively enrolled in the study. The demographic data including age, gender, dominant hand, involved shoulder, body mass index, duration of shoulder pain, practicing sports, and presence of diabetes mellitus were recorded. The ethical committee approval was obtained for the study, and all participants gave written informed consent prior to enrollment.
Patients were included if they fulfilled the following criteria: had impingement symptoms in clinical tests (Neer impingement test, Hawkin sign, Jobe supraspinatus test) for the last 1 to 6 months. 3, 13, 16 All patients had an anteroposterior shoulder radiograph to rule out other causes of shoulder pain, such as osteoarthritis, osseous abnormalities, and calcium deposits. Calcific tendinitis and rotator cuff tear were ruled out using ultrasound imaging. We excluded patients with a previous history of any rheumatic disease, fracture, infection, tumor, shoulder trauma, surgery, corticosteroid injection, or physical therapy for the symptomatic shoulder within the last 6 months.
Patients were divided into 3 groups as follows: NSAID group, kinesiotaping group (NSAID + kinesiotaping application) and injection group (NSAID + subacromial corticosteroid injection). All patients were prescribed etodolac (400 mg 2 times daily) during the 3 weeks. A home-based standardized exercise program (10 repetitions of 1 set daily for each exercise) including Codman pendulum exercises, as well as pain-limited, active shoulder range of motion (ROM) and strengthening (isometric) exercises, were given to all patients after the baseline assessment.
A single corticosteroid injection (methylprednisolone acetate 40 mg with lidocaine 1% in 1 mL) was applied via a palpation-guided posterolateral approach in the injection group.
Kinesiotaping was applied at the end of the baseline evaluation. Patients wore the kinesiotaping for a 4-week duration (renewed in 3Y5 days periodically). A 50 Â 0.5-mm waterproof, porous, and adhesive tape (Kinesio Tex; Kinesio USA, Albuquerque, NM) was used. It was applied onto the supraspinatus and deltoid muscles ( Fig. 1) . The anchor point of the Y strip was taped to the insertion of the supraspinatus muscle, and then the whole strip was taped along the supraspinatus muscle and spine of the scapula toward the muscle_s origin, with paperoff tension with a 20% to 25% stretch. The deltoid muscle was taped using a Y strip as well, which was applied from the anchor site, 3 cm below the deltoid insertion toward its origin, with paper-off tension. The front tail of the Y strip was taped along the
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anterior edge of the deltoid, and the back tail was applied along the posterior edge of the muscle. The third strip was applied from the region of the coracoid process toward the posterior deltoid with a mechanical correction (50%Y75% stretch). 12, 13 In order to avoid bias, clinical examination/ assessment (Z.S $.), kinesiotaping application (S.B.: a certified, kinesiotaping practitioner with 3 years_ experience), and subacromial corticosteroid injections (S $.S $.O.) were performed by the same physiatrists. Patients were evaluated before (baseline) and after the treatment (at the end of the fourth week). At follow-up visits, patients reported continued use of NSAIDs as prescribed. The patients were supervised in order to ensure that exercises were performed correctly/weekly.
Outcome Measures
Pain levels during night, rest, and activity were assessed with a 10-cm visual analog scale (VAS) (0 cm: no pain; 10 cm: worst pain). We considered that a 2-cm decrease in the VAS would be a clinically significant change in this study. 19 Range of motion was measured by using the universal goniometer. To measure shoulder flexion and abduction, examiner measured the ROM of the arms while the patient sitting and extending the elbow joint. The starting shoulder position was 0-degree abduction of the glenohumeral joint, 90-degree flexion of the elbow, and neutral forearm position. Patients moved the affected extremity to the end of a pain-free active ROM of flexion and abduction. For external and internal rotation, patients sat and rotated the shoulder to 90 degrees. The normal ROMs for shoulder flexion and abduction were defined as 180 degrees and for rotations as 90 degrees. 20, 21 For functional disability, Shoulder Disability Questionnaire (SDQ) and University of CaliforniaYLos Angeles (UCLA) scale were used (Tables 1 and 2) . 22 With the UCLA scale, pain, function, active flexion angle, flexion muscle strength, and patient satisfaction were evaluated. Each element of pain and function was assessed with scores from 1 to 10. Active flexion angle, flexion muscle strength, and patient satisfaction were evaluated on a scale of 1 to 5. In total, a score of 34 to 35 was assessed as perfect, 29 to 33 as good, and less than 29 as poor. 23 
Statistical Analysis
All statistical calculations were performed by using SPSS 15.0 program (SPSS Inc, Chicago, Ill). Shapiro-Wilk test was utilized to assess the normal distribution of the variables. A W 2 test was used to compare the distribution of the categorical variables. Paired t test was used to compare the baseline and fourth-week results within the groups. Oneway analyses of variance (with Tamhane post hoc analyses) were performed for the comparison of continuous variables between the groups. Significance level was set at P e 0.05 with a 95% confidence interval.
RESULTS
A total of 113 patients were screened for the enrollment. One hundred two patients met the inclusion criteria and agreed to participate. Three patients could not continue and finish the protocol (Fig. 2 ). There were 33 patients in each group. Tables 3 and 4 . Age, gender, dominant side involved, presence of diabetes mellitus, duration of shoulder pain and VAS scores at rest and activity, shoulder ROM, and SDQ and UCLA scale scores were similar between the groups (all P 9 0.05). Baseline body mass index and VAS scores at night were found to be lower in the NSAID group than in the other groups (P = 0.050 and P = 0.052, respectively). Within each group, significant improvements were observed in all clinical variables (all P G 0.001).
Comparison of the demographic and baseline clinical characteristics is shown in
According to the baseline values, clinically significant differences in $ changes were found in activity VAS, all ROMs, and SDQ and UCLA scale scores between the groups (Table 5 , all P G 0.05). According to the post hoc analyses, although there were no differences between the corticosteroid injection and kinesiotaping groups, there were significant differences between these 2 groups and the NSAID group (all P G 0.05). There was 1 patient in the kinesiotaping group (3%) who reported mild cutaneous irritation related to the kinesiotaping application.
DISCUSSION
To our best knowledge, this is the first study showing/comparing the additional benefits of subacromial corticosteroid injection and kinesiotaping on pain, function, and ROMs in patients with SIS. This study revealed that when used in combination with NSAID treatment kinesiotaping and subacromial corticosteroid injection were similarly effective and superior to NSAID-only treatment in patients with SIS.
The short-term effectiveness of NSAIDs over placebo has been reported in previous studies. 1, 24 Several investigators have evaluated the efficacy of subacromial corticosteroid injection, but the current literature is inconclusive regarding its success. 3, 10 Some studies have shown a significant benefit for subacromial corticosteroid injections in painful shoulder problems, but the authors concluded that this effect might be small and not well maintained. 5,10,11,25 A meta-analysis suggested that there might be some benefits of using a subacromial injection for the treatment of rotator cuff tendinitis, but half of the 8 included studies were of low methodological quality. 11 Only 2 of 4 trials found a difference in pain after treatment of cuff tendinopathy: one showed improvement with NSAIDs in tendonitis, and the other found that corticosteroid injection was beneficial for the small cuff tears. Consequently, corticosteroid injection was reported to be effective in the treatment of SIS, but not more than oral NSAIDs. 1, 11 In contrast, we observed in our study that patients using NSAIDs and subacromial corticosteroid injection demonstrated decreased pain, improved ROM, and better activity level than did those who used only NSAIDs.
Kinesiotaping is thought to elevate the epidermis increasing the pressure on the mechanoreceptors below the dermis, thus decreasing nociceptive stimuli. In addition, kinesiotaping is able to improve blood/lymphatic circulation, reduce pain, realign joints, decrease muscle tension, and increase proprioceptive awareness. 26 Thus, it may help to support the articular structures and reduce soft tissue inflammation and pain. 27 Kaya et al. 12 compared the effectiveness of kinesiotaping with physical therapy, and they found it to be effective for immediate (2- week) functional improvement in SIS. Another study has shown that kinesiotaping application in addition to exercise treatment was more effective than only exercise application in the treatment of SIS. 14 In our study, patients treated with kinesiotaping and NSAIDs showed improvement in pain, ROM, and functional limitation than did those who used only NSAID treatment. On the other hand, in a study performed by Thelen et al., 13 the kinesiotaping group showed immediate improvement in pain-free shoulder abduction, but no other differences were found between therapeutic and sham kinesiotaping groups regarding ROM, pain, or disability scores at any time interval. In that study, they also concluded that without exercise and other treatment modalities kinesiotaping did not significantly reduce pain and improve functions in the short term when compared with sham kinesiotaping. 13 Administration of oral NSAIDs and exercise to each group in our study eliminated this negative effect and allowed better assessment of the effectiveness of kinesiotaping and corticosteroid injection. On the other hand, some studies have shown an immediate beneficial role of kinesiotaping alone in SIS, which was not maintained for a long-term period. 6, 13 As reported, the most effective applications of kinesiotaping appeared within the initial 2 weeks. 6,12Y14 Moreover, Kaya et al. 12 stated that kinesiotaping was a more effective method than physical therapy when a rapid result is required for shoulder pain. Unlike those studies, our study suggested that kinesiotaping has a beneficial effect at least up to 4 weeks. Furthermore, in our study, similar results of kinesiotaping and subacromial corticosteroid injections suggest that these treatment methods can be alternatives to each other.
Limitations
We had some limitations in the current study. First, patients were followed up for a short-term period (4 weeks). Therefore, we cannot comment on the mid-and long-term effects of these different modalities. Second, we did not include a placebo group, which limits the interpretation of our data. Third, we used convenient sampling from a single clinic, which may not be representative of the entire population. Finally, baseline differences between the groups and lack of a power analysis were the other limita-tions of our study. Thus, further placebo-controlled longitudinal studies investigating the long-term effects of these treatments in SIS are required.
CONCLUSIONS
When used in combination with NSAID treatment, kinesiotaping and subacromial corticosteroid injection had similar effectiveness being superior to NSAID-only treatment in patients with SIS. Therefore, we can imply that kinesiotaping + NSAIDs may be used as an alternative to corticosteroids + NSAIDs in patients whereby corticosteroids are contraindicated. www.ajpmr.com
